Sharing-our-perspective




Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • Final approval of the California workers’ compensation MTUS drug formulary

    by
    • Optum Workers' Comp
    | Dec 13, 2017
    Tag Icon
    formulary
    The California Office of Administrative Law has approved the final MTUS Drug Formulary regulations submitted by the Division of Workers’ Compensation (DWC) fully adopting a workers’ compensation drug formulary. The formulary and related rules will go into effect January 1, 2018.


  • Arkansas drug formulary receives legislative approval

    by
    | Dec 08, 2017
    Tag Icon
    Opioids, MED, formulary
    The Arkansas Workers’ Compensation Commission’s (ARWCC) most recent version of their Drug Formulary rule received approval by a legislative oversight committee. This approval permits the ARWCC to move forward with finalization and implementation of the drug formulary.


  • Pennsylvania Senate passes drug formulary

    by
    • Optum Workers' Comp
    | Oct 27, 2017
    Tag Icon
    Workers Comp, Formularies
    The Pennsylvania Senate passed Senate Bill 936 (SB936) on October 25, 2017, with a vote of thirty-four to sixteen, moving the bill to the House for approval. The original version of the bill was passed with no amendments. The bill proposes the state’s Department of Labor and Industry select a nationally recognized, evidence-based prescription drug formulary appropriate for resolving issues related to drugs prescribed for or related to the treatment of work-related injuries.


  • California Division of Workers Compensation submits formulary regulations for final approval

    by
    • Optum Workers' Comp
    | Oct 26, 2017
    Tag Icon
    Workers Comp, DWC, Formularies
    The Division of Workers Compensation (DWC) appears to have submitted what is expected to be the final version of its proposed formulary rules to the Office of Administrative Law (OAL) for final approval more than 60 days prior to the January 1, 2018 effective date.


  • Potential shortages of medical devices manufactured in Puerto Rico

    by
    • Optum Workers' Comp
    | Oct 24, 2017
    Tag Icon
    FDA
    In the wake of Hurricanes Irma and Maria, the U.S. Food and Drug Administration (FDA) has become aware and is monitoring the supply of more than forty drug products, including medical devices, manufactured by facilities in Puerto Rico. As a result of the devastation, lack of power, connectivity, transportation, clean water, raw materials and supplies have all contributed to growing concerns around the potential for critical shortages of medications and medical devices produced in fifty facilities on the island.



Stay informed by receiving latest updates

Do you have a question about a blog post?